A ‘cure’ for haemophilia is one step closer, following results of a groundbreaking gene therapy trial led by the NHS in London.
Clinical researchers at Barts Health NHS Trust and Queen Mary University of London have found that over one year on from a single treatment with a gene therapy drug, participants with haemophilia A (the most common type) are showing normal levels of the previously missing protein, and effectively curing them.
A single infusion of the gene therapy drug showed improved levels of the essential blood clotting protein Factor VIII, with 85 per cent of patients achieving normal or near-normal Factor VIII levels even many months after treatment.
The ‘transformational’ results have particular significance as the first successful gene therapy trial for the haemophilia A.
A hereditary genetic condition
There are around 2000 people with severe haemophilia A in the UK. A hereditary genetic condition dominantly affecting men, people with severe haemophilia A have virtually none of the protein factor VIII which is essential for blood to clot. It puts those affected at risk of excessive bleeding even from the slightest injury as well as causing spontaneous internal bleeding, which can be life-threatening. Recurring bleeding into joints can also lead to progressive joint damage and arthritis. The only current treatment involves multiple weekly injections to control and prevent bleeding, but there is no cure.
The trial saw patients across England injected with a copy of the missing gene, which allows their cells to produce the missing clotting factor. Following patients for up to nineteen months, tests show that eleven out of thirteen patients in the trial now have normal or near normal levels of the previously missing factor and all thirteen patients have been able to stop their previously regular treatment.
Professor John Pasi, Haemophilia Centre Director at Barts Health NHS Trust and Professor of Haemostasis and Thrombosis at Queen Mary University of London explained: “We have seen mind-blowing results which have far exceeded our expectations. When we started out we thought it would be a huge achievement to show a five per cent improvement, so to actually be seeing normal or near normal factor levels with dramatic reduction in bleeding is quite simply amazing. We really now have the potential to transform care for people with haemophilia using a single treatment for people who at the moment must inject themselves as often as every other day. It is so exciting.”
The team will now hold further tests widening participants globally to include people in the USA, Europe, Africa and South America.
Professor Pasi continued: “Incredibly exciting is the potential for a significant change in how haemophilia is treated globally. A single dose of medication that can so dramatically improve the lives of patients across the world is an amazing prospect.”
Professor Jo Martin, President, The Royal College of Pathologists said: “Pathology research is often responsible for ground-breaking developments in diagnoses and treatments that transform the lives of patients.
“What is truly remarkable about this revolutionary new gene therapy are the profound life-changing effects it offers patients with haemophilia. We would like to congratulate College fellow, Professor Pasi, and his team at Barts Health NHS Trust and Queen Mary University of London for their work in creating a simple but transformational treatment for patients.”
Case study
Jake Omer, 29 lives in Billericay and is married with two children, aged 3 years and a baby of 5 weeks. Diagnosed at two years old, he has had frequent injections of factor VIII to prevent bleeds ever since. Before he was treated with the gene therapy, Jake would wake up early before work to inject three times a week as well as injecting whenever he had an injury to stop the bleeding. As a result of of repeated bleeding Jake has arthritis in his ankles. His father is a Turk-Cypriot and as a child he and his family could never travel to visit relatives in case he needed medical care as the facilities wouldn’t have been available.
Jake said: “The gene therapy has changed my life. I now have hope for my future. It is incredible to now hope that I can play with my kids, kick a ball around and climb trees well into my kids’ teenage years and beyond. The arthritis in my ankles meant I used to worry how far I would be able to walk once I turned 40. At 23 I struggled to run 100m to catch a bus; now at 29 I’m walking two miles every day which I just couldn’t have done before having the gene therapy treatment.
“It’s really strange to not have to worry about bleeding or swellings. The first time I noticed a difference was about four months after the treatment when I dropped a weight in the gym, bashing my elbow really badly. I started to panic thinking this is going to be really bad, but after icing it that night I woke up and it looked normal. That was the moment I saw proof and knew that the gene therapy had worked.”
Learn more: Groundbreaking gene therapy trial set to cure haemophilia
The Latest on: Haemophilia
[google_news title=”” keyword=”haemophilia” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- ‘Four of us were infected blood victims — I’m the only one still alive’on May 18, 2024 at 5:57 am
He passed away in 1993 at 31, having contracted HIV from contaminated drugs administered by the NHS to treat his haemophilia. This is Jason’s only memory of his father. But the legacy of his death has ...
- Infected Blood Inquiry: Couple who were shunned and abused as son lay dying hoping for 'justice'on May 17, 2024 at 6:59 pm
The long-awaited report into the infected blood scandal will be released on Monday. Colin and Jan Smith, whose beloved son died aged just seven, hope it will lead to some accountability and help shed ...
- ‘They call us the fatherless ones’: the trauma of families devastated by the infected blood scandal will last for generationson May 17, 2024 at 10:30 am
One person still dies every three days in the UK after receiving contaminated blood in the 1970s and ‘80s. This global scandal has has devastated many families, including those with haemophilia ...
- Infected blood scandal: Who did it affect - and will victims get full compensation?on May 17, 2024 at 9:46 am
Victims of the 'worst treatment disaster in the NHS' will finally get answers on Monday when the inquiry into the infected blood scandal delivers its findings. | ITV National News ...
- 'When I lost him, I lost everything'on May 16, 2024 at 10:37 pm
“That’s how I looked at my dad. So when I lost him, I lost everything,” she added. Mr Burkert was born with the clotting disorder haemophilia A and was given a new treatment called Factor 8, made from ...
- East Yorkshire infected blood victim not alive to see inquiry endon May 14, 2024 at 1:48 pm
The family of an East Yorkshire man given contaminated blood products as a child say they are sad that he did not live to see the end of an inquiry. Nick Sainsbury had severe haemophilia, but his ...
- Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goalson May 14, 2024 at 7:02 am
Novo Nordisk NVO achieved co-primary endpoints in a late-stage study evaluating the efficacy and safety of once-weekly and once-monthly subcutaneous Mim8 compared with no prophylaxis and prior ...
- Emicizumab brings hope to Haemophilia A patients, accessibility remains a challengeon May 7, 2024 at 4:57 am
According to experts, Emicizumab prophylaxis is considered to be a far superior and effective way of managing Haemophilia A in comparison to other traditional treatment options. Current treatment ...
- Haemophilia in children: what parents need to knowon April 22, 2024 at 4:59 pm
Haemophilia, a rare blood disorder affecting clotting, is one such condition that can manifest early in life. It’s a condition where the blood doesn’t clot properly. For most of us ...
- Understanding haemophilia in infants: what parents need to knowon April 21, 2024 at 5:00 pm
Haemophilia, a rare blood disorder affecting clotting, is one such condition that can manifest early in life. It’s essential to understand haemophilia. Simply put, haemophilia is a condition ...
via Google News and Bing News